您的购物车当前为空
别名 PKM2 抑制剂 6
PKM2-IN-6(compound 7d)是一种口服活性的PKM2抑制剂(IC50=23 nM),能够诱导细胞凋亡和G2期细胞周期停滞,在mRNA水平降低PKM1和PKM2的表达,具有抗肿瘤活性,可用于研究三阴性乳腺癌(TNBC)。

PKM2-IN-6(compound 7d)是一种口服活性的PKM2抑制剂(IC50=23 nM),能够诱导细胞凋亡和G2期细胞周期停滞,在mRNA水平降低PKM1和PKM2的表达,具有抗肿瘤活性,可用于研究三阴性乳腺癌(TNBC)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,130 | 现货 | |
| 5 mg | ¥ 2,420 | 现货 | |
| 10 mg | ¥ 3,700 | 现货 |
PKM2-IN-6 相关产品
| 产品描述 | PKM2-IN-6 (compound 7d) is an orally active PKM2 inhibitor (IC50=23 nM) capable of inducing apoptosis and G2 cell cycle arrest. It reduces PKM1 and PKM2 expression at the mRNA level, exhibits antitumour activity, and is suitable for investigating triple-negative breast cancer (TNBC). |
| 体外活性 | PKM2-IN-6(compound 7d) (0-100 μM)处理 COLO-205、A-549、MCF-7 细胞 48 小时后,对三种细胞均表现出细胞毒性,IC₅₀分别为 18.33 μM、47.00 μM 和 19.80 μM [1]。 |
| 体内活性 | PKM2-IN-6 (25和50 mg/kg,口服,每日一次,持续三周)能显著降低接种了4T1-Red-FLuc细胞的雌性CD-1裸鼠(6-8周龄)的肿瘤体积和重量[1]。 |
| 别名 | PKM2 抑制剂 6 |
| 分子量 | 322.38 |
| 分子式 | C17H14N4OS |
| CAS No. | 771467-00-6 |
| Smiles | N(C1=NC(C=2N3C(=NC2)C=CC=C3)=CS1)C4=C(OC)C=CC=C4 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (310.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容